This article is more than 5 years old. Information may no longer be current.

VIDEO: Steroid challenge predictive of IOP lowering in eyes with fluocinolone implants

ByVictor H. Gonzalez, MD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

CHICAGO — At the American Society of Retina Specialists meeting, Victor H. Gonzalez, MD, summarizes a trial on the real-world use of Iluvien (fluocinolone acetonide intravitreal implant 0.19 mg, Alimera Sciences) in patients with diabetic macular edema and the predictability of what happens to IOP in patients with the implant who require supplemental steroids.